Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Jerome Benedict Durso is President and CEO at Altimmune. OQRO lists 1 transaction filed with the SEC under this name, the latest on Nov 13, 2026, each linked to the official Form 4.
President and CEO
Disclosures on record
1
Companies involved
1
Jerome Benedict Durso bought shares on the open market in 2026.
Jerome Benedict Durso reported 1 open-market purchase and 0 sales since 2026; purchases in 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $50K1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
AltimmuneALT
Nov 13, 2026Bought~$50K
DetailsOfficial recordAs of the latest filing on , Jerome Benedict Durso reported holding 93,200 shares of Altimmune (ALT), worth about $153K at the last close of $2 (Nov 13, 2026). In the last 12 months, Jerome Benedict Durso bought $50K in 1 open-market purchase.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Altimmune ALT | 93,200 | 93K direct | $2 | $153K | Nov 13, 2026 |
Is this Jerome Benedict Durso’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Nov 13, 2026, Jerome Benedict Durso reported holding 93,200 shares of Altimmune (ALT). At the last close of $2 on Nov 13, 2026, that is about $153K. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Jerome Benedict Durso reported 1 open-market purchase worth $50K, and no open-market sale. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Jerome Benedict Durso bought shares on the open market in 2026.
In SEC filings since 2026: the latest open-market purchase is from 2026; no open-market sale is on record.
Altimmune (ALT), from 2026 to 2026: 1 purchase and 0 sales.
Jerome Benedict Durso reported 1 open-market purchase and 0 sales here, 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
